Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04412590 · ClinicalTrials.gov registry record · NA
Pilot Study of the Vermont Family Based Approach in Primary Care Pediatrics
A NA study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT04412590: Completed NA study, sponsored by University of Vermont Medical Center.
NCT04412590 is a NA study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04412590, a NA study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This pilot randomized controlled trial of the Vermont Family Based Approach (VFBA) tested the feasibility of the VFBA in primary care pediatrics and its effects on children's and parents' emotional and behavioral problems and health-related quality of life. The VFBA is a public health framework for evidence-based health promotion, prevention, and treatment that is delivered from the family perspective and emphasizes emotional and behavioral health. The VFBA group received the VFBA intervention, while the Control group received pediatric primary care as usual.
Primary Outcome
descriptive statistics for the number of family visits with FWCs
Interventions
- OTHER Treatment as Usual
- OTHER Vermont Family Based Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-12-01 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT04412590 record still lists
NCT04412590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT04412590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04412590 about?
NCT04412590 is a clinical study titled "Pilot Study of the Vermont Family Based Approach in Primary Care Pediatrics". This pilot randomized controlled trial of the Vermont Family Based Approach (VFBA) tested the feasibility of the VFBA in primary care pediatrics and its effects on children's and parents' emotional and behavioral problems and health-related quality of life. The VFBA is a public health framework for ...
What is the current status of trial NCT04412590?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-12-01. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT04412590?
The interventions under investigation include: Treatment as Usual (OTHER), Vermont Family Based Approach (OTHER).
Who is sponsoring clinical trial NCT04412590?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04412590's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI